Nefense®, a pioneer in advanced clinical hygiene and airway health solutions, today announced the official launch of its Hypochlorous Acid (HOCl) nasal spray line. The product family includes Hyponasal, Hyponasal Junior, and Hypobaby, offering age-specific, drug-free nasal care solutions for adults, children, and infants.
The flagship product, Hyponasal HOCl Nose Spray, is formulated as an effective biocleanse for nasal passages and mucosal linings. It helps flush away environmental irritants while supporting the body's natural respiratory defenses without harsh chemicals, medications, or steroids. According to Dr. Richard D. Downs, D.D.S., “Proper airway management begins with maintaining a clean and healthy nasal cavity. With Hyponasal, we are providing a superior biocleanse solution that addresses daily irritation at its source.”
At the core of the Nefense nasal spray line is Ionoxx Hypochlorous Acid (HOCl), a naturally occurring molecule produced by the immune system. HOCl has anti-microbial and anti-inflammatory properties, making it suitable for nasal hygiene. Dr. Joseph Zelk, a sleep specialist, noted, “The anti-inflammatory and antimicrobial properties of HOCl make it a remarkable tool for naturally clearing the airway, mitigating allergies, and supporting healthier breathing.”
Recognizing the need for airway health at every age, Nefense introduces Hyponasal Jr. and Hypobaby for children and infants. These formulations deliver the same cleansing technology while being tailored for sensitive nasal passages. Dr. Shane Smith stated, “Parents constantly struggle to find safe, drug-free solutions for their children’s congestion. Hypobaby and Hyponasal Jr. offer unparalleled peace of mind.”
Consumer interest in respiratory wellness is growing, with many seeking products for airway wellness, nasal hygiene, and drug-free allergy management. With this launch, Nefense expands its portfolio of science-driven airway wellness products. For more information, visit Nefense.com.
